Novavax's stock pops after WHO grants its COVID-19 vaccine emergency-use listing
Novavax's protein-based vaccine can now be offered to all 194 member nations of the WHO, as well as Unicef and other agencies.
Stay updated with breaking news from Johnc Jacobs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novavax's protein-based vaccine can now be offered to all 194 member nations of the WHO, as well as Unicef and other agencies.
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Nuvaxovid™...
New organizational structure for executive leadership team designed to facilitate a leaner and more focused approach to annual execution of business plansJohn Trizzino appointed to new Chief...
GAITHERSBURG, Md., Nov. 10, 2023 /PRNewswire/ -- Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will participate in the...
Received authorization from the U.S. FDA and approval from the European Commission for the Company's updated COVID-19 vaccine, and launched the only...